 | Anton J. Enright, Group Leader, EMBL - European Bioinformatics Institute Recently, small RNAs such as microRNA (miRNAs) have been demonstrated to be important regulators in both plants and animals... To read more "MicroRNA" articles click here |
 | Stephen A bustin BA(Mod) PhD, Professor of Molecular Science, Queen Mary University of London The fluorescence-based quantitative real-time polymerase chain reaction (qPCR) has become firmly established as the preferred technology for the detection and quantification of nucleic acids in molecular diagnostics, life sciences, agriculture and medicine... To read more "qPCR" articles click here |
 | Dr Anne Katrin Werenskiold, Project Manager, Interaction Proteome, Max Planck Institute of Biochemistry In its Research Framework Programme 7 (2007-2013), the European Commission sets the focus in health research on bringing the huge high-throughput data collection efforts of earlier programmes to the systems level... To read more "Proteomics" articles click here |
 | Dr Stefan Przyborski, chief Scientific Officer, Reinnervate Limited, School of Biological and Biomedical Science, Durham University The development of pharmaceuticals and screening the biological activity of test compounds is a multi-staged process spanning from small molecule design and synthesis, in vitro testing, and compound evaluation in vivo using and human trials... To read more "Stem Cells" articles click here |
 | Yuri Volkov, Paul J Spiers and Dr Anthony Davies, HCA Research Facility Manager, Trinity college Dublin Approximately 45% of all deaths and 50% of all hospitalisations in the western world are a direct result of cardiovascular disease... To read more "High Content Screening" articles click here |
| Dr Sheraz Gul, Vice President and Head of Biology, European ScreeingPort GmbH High Throughput Screening (HTS) has for many years now been playing a central role in drug discovery efforts to aid the identification of small molecule chemical entities that are capable of modifying the activity of disease relevant targets... To read more "Lab Automation" articles click here |
 | David E. Ray, Associate Professor of Neurotoxicology, School of Biomedical Sciences, University of Nottingham, United Kingdom Neurotoxicology is not a discipline that can expect to be popular in pharmaceutical circles... To read more "Toxicology" articles click here |
 | Jakob Beirowski, Pharmacist and Dr. Henning Gieseler, Assistant Professor, Division of Pharmaceutics, University of Erlangen-Nuremberg Freeze drying of pharmaceuticals requires and adequate formulation design to prevent low-temperature, freezing and drying stresses... To read more "Freese Drying / Thermal Analysis" articles click here |
 | Darren Wallis, Quality Assurance Microbiologist, GlaxoSmithKline The design, validation and implementation of a documented and approved disinfectant programme must form a key part of any pharmaceutical production area qualification... To read more "Aseptic Processing" articles click here |
 | Linda Skowronsky, Senior Development Microbiologist, GlaxoSmithKline During stability, product testing is a performed to ensure the product will continue to meet specified criteria of quality and strength through its expiration or shelf-life at the temperature and humidity required by specific markets... To read more "Microbiology" articles click here |
 | Julian Morris, Professor of Process Control and Technical Director at the Centre for Process Analytics and Control Technology (CPACT) and Dr Zengping Chen, Chemical Engineering and Advanced Materials, Newcastle University, UK Pharma-Chem and bio-pharma development and production are now being profoundly influenced by the FDA PAT initiative with spectroscopic instrumentation being increasingly applied, or at the very least explored in product and process development and for on-line real-time process applications... To read more "PAT" articles click here |
.jpg)
